BEAT: Binge-Eating Adolescent Treatment - a training program for adolescents and young adults with binge-eating

Not Applicable

• Conditions: The treatment program is conducted in a within-subject control design. Therefore, no control groups will be added to the study design for the treatment study.However, for the experimental paradigms, a healthy control group consisting of healthy adolescents, 14-19 years of age, without any mental disorder will be recruited. Binge eating disorderRepeated binge eatingLoss of control eating (LOC); F50.8; Other eating disorders

• Registration Number: DRKS00014580
• Lead Sponsor: niversität Fribourg/Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-21
• Study Completion: 2021-08-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

full diagnosis of Binge-Eating-Disorder or subclinical diagnosis according to DSM-5 (binge-eating episodes occur less than once a week and/or for less than 3 months) or at least one episode of Loss of Control Eating over different quantities of food (LOC) in the past six months.
- written declaration of consent
- German language

Exclusion Criteria

- Language: patients will be excluded if they do not have self-reported sufficient German language skills.
- current Bulimia Nervosa or Anorexia Nervosa
- Presence of another serious psychological or medical condition that warrants priority treatment (acute substance abuse, psychosis, acute, severe major depression)
- pregnancy
- concurrent participation in a diet program
- Concurrent participation in a psychotherapy on eating disorders
- Previous enrollment into the current study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pre- to post treatment: weekly binge-eating episodes, abstinence rate (frequency of binge-eating episodes during the last months), frequency of BED diagnosis, feasibility. Data are assessed with self-report questionnaires and therapist ratings (structured interviews) at the following measurement-points (pre- post comparison): Before- and after treatment and after the third and fourth follow-up assessment. Weekly binges are assessed weekly during active treatment.

Secondary Outcome Measures

Name	Time	Method
BEAT: reduction of general psychopathology.<br>Social rejection sensitivity: attention bias and experienced rejection during two experimental investigations, pre- to post treatment and in comparison with a healthy control group (pre-treatment).<br>Epigenetic: predictive relevance and change of DNA methylation levels following the CBT treatment and in comparison to healthy controls will be investigated exploratively. Data of the two experimental paradigms and epigenetic examinations will be assessed before and after the treatment (experimental paradigms in the healthy control group will only be conducted at pre-measurement). Self-reported social rejection sensitivity (questionnaire) will be assess before- and after treatment and after the 6 ans 12 month follow-up.